Suppr超能文献

高度功能化吡唑腙和酰胺的结构-活性关系研究作为抗增殖和抗氧化剂。

Structure-Activity Relationship Studies on Highly Functionalized Pyrazole Hydrazones and Amides as Antiproliferative and Antioxidant Agents.

机构信息

Department of Pharmacy, University of Genova, Viale Benedetto XV, 3, 16132 Genova, Italy.

Proteomics and Mass Spectrometry Unit, IRCCS Ospedale Policlinico San Martino, Largo R. Benzi 10, 16132 Genova, Italy.

出版信息

Int J Mol Sci. 2024 Apr 23;25(9):4607. doi: 10.3390/ijms25094607.

Abstract

Aminopyrazoles represent interesting structures in medicinal chemistry, and several derivatives showed biological activity in different therapeutic areas. Previously reported 5-aminopyrazolyl acylhydrazones and amides showed relevant antioxidant and anti-inflammatory activities. To further extend the structure-activity relationships in this class of derivatives, a novel series of pyrazolyl acylhydrazones and amides was designed and prepared through a divergent approach. The novel compounds shared the phenylamino pyrazole nucleus that was differently decorated at positions 1, 3, and 4. The antiproliferative, antiaggregating, and antioxidant properties of the obtained derivatives - were evaluated in in vitro assays. Derivative showed relevant antitumor properties against selected tumor cell lines (namely, HeLa, MCF7, SKOV3, and SKMEL28) with micromolar IC values. In the platelet assay, selected pyrazoles showed higher antioxidant and ROS formation inhibition activity than the reference drugs acetylsalicylic acid and -acetylcysteine. Furthermore, in vitro radical scavenging screening confirmed the good antioxidant properties of acylhydrazone molecules. Overall, the collected data allowed us to extend the structure-activity relationships of the previously reported compounds and confirmed the pharmaceutical attractiveness of this class of aminopyrazole derivatives.

摘要

氨比唑类化合物在药物化学中具有重要意义,许多衍生物在不同的治疗领域表现出了生物活性。之前报道的 5-氨比唑酰腙和酰胺显示出了相关的抗氧化和抗炎活性。为了进一步扩展这一类衍生物的构效关系,通过发散方法设计和制备了一系列新型的吡唑酰腙和酰胺。这些新化合物具有相同的苯基氨基吡唑核,在 1、3 和 4 位上有不同的取代基。获得的衍生物的抗增殖、抗聚集和抗氧化特性在体外试验中进行了评估。化合物 对选定的肿瘤细胞系(即 HeLa、MCF7、SKOV3 和 SKMEL28)具有相关的抗肿瘤特性,其 IC 值为微摩尔级。在血小板试验中,与对照药物乙酰水杨酸和 -乙酰半胱氨酸相比,所选的吡唑类化合物具有更高的抗氧化和 ROS 形成抑制活性。此外,体外自由基清除筛选证实了酰腙分子的良好抗氧化特性。总的来说,收集到的数据扩展了之前报道的化合物的构效关系,并证实了这类氨基吡唑衍生物的药物吸引力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a360/11083148/e23cc9cd30cd/ijms-25-04607-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验